BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25961062)

  • 1. IL-10 and ARG-1 concentrations in bone marrow and peripheral blood of metastatic neuroblastoma patients do not associate with clinical outcome.
    Morandi F; Croce M; Cangemi G; Barco S; Rigo V; Carlini B; Amoroso L; Pistoia V; Ferrini S; Corrias MV
    J Immunol Res; 2015; 2015():718975. PubMed ID: 25961062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients.
    Yáñez Y; Hervás D; Grau E; Oltra S; Pérez G; Palanca S; Bermúdez M; Márquez C; Cañete A; Castel V
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):573-80. PubMed ID: 26498952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring circulating neuroblastoma cells by quantitative reverse transcriptase-polymerase chain reaction analysis.
    Cheung IY; Sahota A; Cheung NK
    Cancer; 2004 Nov; 101(10):2303-8. PubMed ID: 15484213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of minimal disease in the bone marrow and peripheral blood in neuroblastoma.
    Shono K; Tajiri T; Fujii Y; Suita S
    J Pediatr Surg; 2000 Oct; 35(10):1415-20. PubMed ID: 11051140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4
    Morandi F; Pozzi S; Barco S; Cangemi G; Amoroso L; Carlini B; Pistoia V; Corrias MV
    Oncoimmunology; 2016; 5(12):e1249553. PubMed ID: 28123887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma.
    Yáñez Y; Grau E; Oltra S; Cañete A; Martínez F; Orellana C; Noguera R; Palanca S; Castel V
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1263-72. PubMed ID: 21706131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble HLA-G and HLA-E Levels in Bone Marrow Plasma Samples Are Related to Disease Stage in Neuroblastoma Patients.
    Morandi F; Pozzi S; Carlini B; Amoroso L; Pistoia V; Corrias MV
    J Immunol Res; 2016; 2016():7465741. PubMed ID: 27610393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus nephritis: correlation of immunohistochemical expression of C4d, CD163-positive M2c-like macrophages and Foxp3-expressing regulatory T cells with disease activity and chronicity.
    Allam M; Fathy H; Allah DA; Salem MAE
    Lupus; 2020 Jul; 29(8):943-953. PubMed ID: 32580679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD163
    Shigeoka M; Koma YI; Nishio M; Komori T; Yokozaki H
    Clin Exp Dent Res; 2019 Dec; 5(6):627-637. PubMed ID: 31890299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4
    Niedźwiecki M; Budziło O; Zieliński M; Adamkiewicz-Drożyńska E; Maciejka-Kembłowska L; Szczepański T; Trzonkowski P
    J Immunol Res; 2018; 2018():1292404. PubMed ID: 30003111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma.
    Komada Y; Zhang XL; Zhou YW; Inaba H; Deguchi T; Azuma E; Sakurai M
    Cancer; 1998 Feb; 82(3):591-9. PubMed ID: 9452279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumors.
    van Dongen M; Savage ND; Jordanova ES; Briaire-de Bruijn IH; Walburg KV; Ottenhoff TH; Hogendoorn PC; van der Burg SH; Gelderblom H; van Hall T
    Int J Cancer; 2010 Aug; 127(4):899-909. PubMed ID: 20013807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of initial bone marrow disease detection by multiparameter flow cytometry in children with neuroblastoma.
    Popov A; Druy A; Shorikov E; Verzhbitskaya T; Solodovnikov A; Saveliev L; Tytgat GAM; Tsaur G; Fechina L
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):535-542. PubMed ID: 30603901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.
    Miyajima Y; Kato K; Numata S; Kudo K; Horibe K
    Cancer; 1995 Jun; 75(11):2757-61. PubMed ID: 7743482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
    Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
    Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.
    Maniecki MB; Etzerodt A; Ulhøi BP; Steiniche T; Borre M; Dyrskjøt L; Orntoft TF; Moestrup SK; Møller HJ
    Int J Cancer; 2012 Nov; 131(10):2320-31. PubMed ID: 22362417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple target molecular monitoring of bone marrow and peripheral blood samples from patients with localized neuroblastoma and healthy donors.
    Corrias MV; Haupt R; Carlini B; Cappelli E; Giardino S; Tripodi G; Tonini GP; Garaventa A; Pistoia V; Pistorio A
    Pediatr Blood Cancer; 2012 Jan; 58(1):43-9. PubMed ID: 21254375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction.
    Kuroda T; Saeki M; Nakano M; Mizutani S
    J Pediatr Surg; 1997 Jan; 32(1):69-72. PubMed ID: 9021573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of neuroblastoma cells in bone marrow and peripheral blood by different techniques: accuracy and relationship with clinical features of patients.
    Corrias MV; Faulkner LB; Pistorio A; Rosanda C; Callea F; Piccolo MS; Scaruffi P; Marchi C; Lacitignola L; Occhino M; Gambini C; Tonini GP; Haupt R; De Bernardi B; Pistoia V; Garaventa A
    Clin Cancer Res; 2004 Dec; 10(23):7978-85. PubMed ID: 15585633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts.
    Zhao XY; Wang YT; Mo XD; Zhao XS; Wang YZ; Chang YJ; Huang XJ
    J Transl Med; 2015 May; 13():145. PubMed ID: 25948100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.